Form 8-K - Current report:
SEC Accession No. 0001628280-18-012188
Filing Date
2018-10-01
Accepted
2018-10-01 17:26:35
Documents
1
Period of Report
2018-10-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K CALDOLOR UPDATE 10012018 caldolor8-k10012018.htm 8-K 24151
  Complete submission text file 0001628280-18-012188.txt   25155
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 181098575
SIC: 2834 Pharmaceutical Preparations